Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Pedroso, Dora C S ^a,b   Tellechea, Ana ^a   Moura, Liane ^a   Fidalgo Carvalho, Isabel ^c   Duarte, João ^d   Carvalho, Eugénia ^a   Ferreira, Lino ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Biocant Biotechnology Innovation Center   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d Crioestaminal ^*  (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; CD34 ANTIGEN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD34 SELECTION; CELL ADHESION; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL ISOLATION; CELL SURVIVAL; CHRONIC WOUND; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; TISSUE ENGINEERING; TISSUE REGENERATION; UMBILICAL CORD BLOOD; WOUND HEALING; BLOOD VESSEL; CYTOLOGY; INFLAMMATION; PHYSIOLOGY; SECRETION; STEM CELL; UMBILICAL VEIN;

ANIMALIA;

ANTIGENS, CD34; BLOOD VESSELS; CELL DIFFERENTIATION; CELL SURVIVAL; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; UMBILICAL VEINS; WOUND HEALING;

EID: 79551528768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016114     Document Type: Article

References (38)

1. Pradhan L, Nabzdyk C, Andersen ND, LoGerfo FW, Veves A (2009) Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med 11: e2.
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366: 1719-1724.
3. Cha J, Falanga V (2007) Stem cells in cutaneous wound healing. Clin Dermatol 25: 73-78.
4. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366: 1736-1743.
5. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC (2003) CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 40: 368-377.
6. Caballero S, Sengupta N, Afzal A, Chang KH, Li Calzi S, et al. (2007) Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 56: 960-967.
7. Barcelos LS, Duplaa C, Krankel N, Graiani G, Invernici G, et al. (2009) Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 104: 1095-1102.
8. Wu Y, Chen L, Scott PG, Tredget EE (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25: 2648-2659.
9. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, et al. (2003) High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A 100: 645-650.
10. Leor J, Guetta E, Chouraqui P, Guetta V, Nagler A (2005) Human umbilical cord blood cells: a new alternative for myocardial repair? Cytotherapy 7: 251-257.
11. Valbonesi M, Giannini G, Migliori F, Dalla Costa R, Dejana AM (2004) Cord blood (CB) stem cells for wound repair. Preliminary report of 2 cases. Transfus Apher Sci 30: 153-156.
12. Smadja D, Basire A, Amelot A, Conte A, Bieche I, et al. (2008) Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 12: 975-986.
13. Ghajar CM, Chen X, Harris JW, Suresh V, Hughes CC, et al. (2008) The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J 94: 1930-1941.
14. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437.
15. Deng X, Ruvolo P, Carr B, May WS, Jr. (2000) Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci U S A 97: 1578-1583.
16. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83: 835-870.
17. Janmey PA, Winer JP, Weisel JW (2009) Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6: 1-10.
18. de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, et al. (2006) Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol 26: 1653-1659.
19. Finkenzeller G, Graner S, Kirkpatrick CJ, Fuchs S, Stark GB (2009) Impaired in vivo vasculogenic potential of endothelial progenitor cells in comparison to human umbilical vein endothelial cells in a spheroid-based implantation model. Cell Prolif 42: 498-505.
20. Behringer D, Kresin V, Henschler R, Mertelsmann R, Lindemann A (1997) Cytokine and chemokine production by CD34+ haemopoietic progenitor cells: detection in single cells. Br J Haematol 97: 9-14.
21. Scheubel RJ, Holtz J, Friedrich I, Borgermann J, Kahrstedt S, et al. (2008) Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting. Int J Cardiol.
22. Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, et al. (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167: 4137-4140.
23. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, et al. (2005) CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97: 314-322.
24. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21: 467-476.
25. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, et al. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627.
26. Tang H, Guo Z, Zhang M, Wang J, Chen G, et al. (2006) Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10. Blood 108: 1189-1197.
27. Chen CC, Manning AM (1996) TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 8: 58-65.
28. Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, et al. (1996) Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood 88: 2549-2558.
29. Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, et al. (2002) VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417: 954-958.
30. Parada Y, Banerji L, Glassford J, Lea NC, Collado M, et al. (2001) BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression. J Biol Chem 276: 23572-23580.
31. Ratajczak J, Zhang Q, Pertusini E, Wojczyk BS, Wasik MA, et al. (1998) The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions-comparison to other cytokines and growth factors. Leukemia 12: 371-381.
32. Geest CR, Buitenhuis M, Groot Koerkamp MJ, Holstege FC, Vellenga E, et al. (2009) Tight control of MEK-ERK activation is essential in regulating proliferation, survival, and cytokine production of CD34+-derived neutrophil progenitors. Blood 114: 3402-3412.
33. Lozito TP, Kuo CK, Taboas JM, Tuan RS (2009) Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem 107: 714-722.
34. Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3: e1886.
35. Henning RJ, Burgos JD, Ondrovic L, Sanberg P, Balis J, et al. (2006) Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 15: 647-658.
36. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, et al. (2005) Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14: 595-604.
37. Nakamuta JS, Danoviz ME, Marques FL, dos Santos L, Becker C, et al. (2009) Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One 4: e6005.
38. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.